Context Therapeutics CNTX Insider Ownership

NASDAQ CNTX
$0.24 +0.01 (+2.27%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

1.04Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.25%
■0% pp QoQ
Shares Held by Insiders
1.19Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
95.18Mn
95,183,718 shares
Direct Holdings
268.71K
Indirect: 920.19K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
4
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the trailing 12 months, CNTX insiders made no open-market trades in the stock.

Form 4 Holdings

Insiders Holding CNTX

Insiders 4
Shares held 1.04Mn
Of outstanding 1.09%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Martin A. Lehr Chief Executive Officer 0 920,190 920,190 88.5% 10 Jun, 2025
2 Jennifer Lynn Minai-Azary Chief Financial Officer 80,010 0 80,010 7.7% 10 Jun, 2025
3 Alex C. Levit Chief Legal Officer, Corp. Sec 29,000 0 29,000 2.8% 10 Jun, 2025
4 Tarek Sahmoud Chief Medical Officer 10,000 0 10,000 1.0% 17 Aug, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

85 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
24 Jun, 2026 Jennifer Evans Stacey Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Philip W. Kantoff Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Luke Nathaniel Walker Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Andy Pasternak Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Linda West Director Acquired A 45,000 $0.00 $0 45,000 Direct
24 Jun, 2026 Karen L. Smith Director Acquired A 45,000 $0.00 $0 45,000 Direct
19 Feb, 2026 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired A 270,000 $0.00 $0 270,000 Direct
19 Feb, 2026 Martin A. Lehr Chief Executive Officer Acquired A 815,000 $0.00 $0 815,000 Direct
19 Feb, 2026 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired A 275,000 $0.00 $0 275,000 Direct
19 Feb, 2026 Karen Deborah Chagin Chief Medical Officer Acquired A 290,000 $0.00 $0 290,000 Direct
12 Jun, 2025 Linda West Director Acquired A 123,500 $0.00 $0 123,500 Direct
12 Jun, 2025 Luke Nathaniel Walker Director Acquired A 123,500 $0.00 $0 123,500 Direct
12 Jun, 2025 Philip W. Kantoff Director Acquired A 123,500 $0.00 $0 123,500 Direct
12 Jun, 2025 Jennifer Evans Stacey Director Acquired A 123,500 $0.00 $0 123,500 Direct
12 Jun, 2025 Andy Pasternak Director Acquired A 138,900 $0.00 $0 138,900 Direct
12 Jun, 2025 Karen L. Smith Director Acquired A 123,500 $0.00 $0 123,500 Direct
06 Jun, 2025 Alex C. Levit Chief Legal Officer, Corp. Sec Acquired P 20,000 $0.58 $11.52K 29,000 Direct
09 Jun, 2025 Martin A. Lehr Chief Executive Officer Acquired P 100,000 $0.70 $70.08K 920,190 Indirect
06 Jun, 2025 Jennifer Lynn Minai-Azary Chief Financial Officer Acquired P 40,010 $0.64 $25.49K 80,010 Direct
09 Jun, 2025 Karen Deborah Chagin Chief Medical Officer Acquired A 153,000 $0.00 $0 153,000 Direct